Home / LP Directory / Corporate Investors / Changzhou / Jiangsu Quality Horizons Pharmtech
Corporate Investor • Changzhou, China

Jiangsu Quality Horizons Pharmtech

Jiangsu Quality Horizons Pharmtech is a corporate investor based in Changzhou, China, founded in 2001. Verified contact details, AUM data, and investment preferences on FindLPs.

$153M
Assets Under Mgmt
2001
Year Founded
Corporate Investor
Investor Type
Changzhou, China
Headquarters
About

Jiangsu Quality Horizons Pharmtech

Jiangsu Qihui Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Qihui Pharmaceutical") has invested in and built three production bases (Changzhou Qihui Pharmaceutical Co., Ltd., Inner Mongolia Qihui Pharmaceutical Co., Ltd., and Jiangsu Youliwei Biopharmaceutical Co., Ltd.). It is a modern enterprise integrating the research and development, production and sales of antiperspirants...

Investment Focus

What Jiangsu Quality Horizons Pharmtech Invests In

Investment types: Early Stage, Early Stage: Seed, Early Stage: Start-up, Expansion / Late Stage, Growth, Venture (General)

Sectors & themes: Diversified, Healthcare, Information Technology

Preferred geographies: Asia, BRIC, Emerging Markets, Greater China

Location: No. 18 Jinlong Road, Chunjiang Town Xinbei District

Contact Jiangsu Quality Horizons Pharmtech

FindLPs holds verified direct email addresses and phone numbers for decision-makers at Jiangsu Quality Horizons Pharmtech. Contact details are masked on the free plan — start a plan to unlock full access and CSV export.

Unlock Contact Details

Find LPs like Jiangsu Quality Horizons Pharmtech

Search 25,850 limited partners with verified contact details.

LP firm data compiled from public regulatory filings (SEC Form ADV, FCA, AIFMD disclosures), company websites and press releases, LinkedIn public profiles, and verified outbound email testing. AUM figures reflect self-reported values from filings and may lag by 1–2 fiscal quarters; bands are normalized in USD. We do not publish personal residential information; firms or individuals may request removal at /contact. Methodology & sources · Updated July 2026.